Gabriella Nicolini

9PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyAtomic and molecular physicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment.

|Mar 13, 2024
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells.

Martina Giambra, Andrea Di Cristofori, Francesca Raimondo

|Jan 26, 2024
The Role of NMNAT2/SARM1 in Neuropathy Development.

Olga Tarasiuk, Laura Molteni, Alessio Malacrida

|Sep 14, 2022
AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules.

Olga Tarasiuk, Matteo Miceli, Alessandro Di Domizio

|Sep 09, 2022
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?

Elisa Ballarini, Alessio Malacrida, Virginia Rodriguez-Menendez

|Jan 21, 2022
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines.

Alessio Malacrida, Alessandro Di Domizio, Angela Bentivegna

Pageof 2

Frequent Collaborators

3 joint publications

Guido Cavaletti

3 joint publications

Angela Bentivegna

2 joint publications

Valentina Zuliani

2 joint publications

Silvia Maria Tabano